SPPI News and Press, Spectrum Pharmaceuticals Inc. From 09/25/20

Should These Biotech Penny Stocks Be On Your List Right Now? Biotech penny stocks are some of the most sought after in the stock market today. It isn’t because they’re leading the market. For the most part, investors look to these penny stocks for their future potentia...

Nikola Corporation (NKLA) -26% after Milton resignation sends shockwaves.Eastman Kodak (KODK) -11%.Uranium Energy (UEC) -9%.Eton Pharmaceuticals (ETON) -7%.Deutsche Bank Aktiengesellschaft (DB) -7% on money laundering allegations.ING Groep N.V. (ING) -7%.Plug Power (PLUG) ...

Spectrum Pharmaceuticals (NASDAQ: SPPI ) has announced additional results from its Phase 2 (ZENITH20) trial, evaluating poziotinib in previously treated non-small cell lung cancer (NSCLC) patients with HER2 exon 20 insertion mutations (Cohort 2). Data were at the European Society for Medic...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today presented additional results from its pivotal Phase 2 clinical trial, ZENITH20, evaluating poziotinib in previously treated non-small cell lung cancer (NSCLC) patient...

JMP Securities initiated Spectrum Pharmaceuticals ( SPPI +8.6% ) with an Outperform rating, PT $12; stock has garnered 101% in past 6 months trading. More news on: Spectrum Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Looking For Penny Stocks To Buy Now? What do you look for when identifying penny stocks to buy ? Are you a technical trader looking for chart patterns? Is penny stock news the first thing you look for? There are plenty of strategies to use to make money in the stock market today. You’...

Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, today announced a presentation of the results for Cohort 2 from its Phase 2 clinical trial, ZENITH20, evaluating poziotinib in previously treated non-small cell lung cancer...

Spectrum Pharmaceuticals, Inc. (SPPI) Q2 2020 Earnings Conference Call August 10, 2020 04:30 PM ET Company Participants Kurt Gustafson - Chief Financial Officer Joe Turgeon - President & Chief Executive Officer François Lebel - Chief Medical Officer Tom Riga - Chief ...

Image source: The Motley Fool. Spectrum Pharmaceuticals Inc   (NASDAQ: SPPI) Q2 2020 Earnings Call Aug 10, 2020 , 4:30 p.m. ET Operator Continue reading

Spectrum Pharmaceuticals (NASDAQ: SPPI ) : Q2 GAAP EPS of -$0.29 beats by $0.03 . cash, cash equivalents, and marketable securities of $156.5M Press Release More news on: Spectrum Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news,